Within Life Science and biotech companies, upcoming news flow in the form of price triggers

The biotech companies are having difficulties in terms of stock prices, initially driven by rising

Software-as-a-Service as a growth sector did like many other sectors not avoid price drops caused

The ViroGates share has shown strong performance with an increase of almost 100% this year

With good prospects for Orviglance(previously known as Mangoral) we expect coming phase 3 data due

Evaxion Biotechis a Danish pharmaceutical company listed at Nasdaq Stock Market in the US. The